Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
With a market cap of 8.17B, Halozyme Therapeutics(HALO) trades at $70.00. The stock has a price-to-earnings ratio of 27.51.
On 2026-02-26, Halozyme Therapeutics(HALO) stock traded between a low of $68.38 and a high of $70.17. Shares are currently priced at $70.00, which is +2.4% above the low and -0.2% below the high.
Halozyme Therapeutics(HALO) shares are trading with a volume of 2.1M, against a daily average of 2.3M.
During the past year, Halozyme Therapeutics(HALO) stock moved between $47.50 at its lowest and $82.22 at its peak.
During the past year, Halozyme Therapeutics(HALO) stock moved between $47.50 at its lowest and $82.22 at its peak.
HALO News
Halozyme Therapeutics (NasdaqGS:HALO) reported a quarterly net loss after recording a major impairment charge. The company outlined plans to actively pursue ac...
Analyst ratings
63%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.